Simavita Limited
TSX VENTURE : SV
ASX : SVA

Simavita Limited

December 03, 2014 13:00 ET

Simavita Limited: Results From 2014 Annual General and Special Meeting

SYDNEY, AUSTRALIA--(Marketwired - Dec. 3, 2014) - Simavita Limited ("Simavita" or the "Company") (ASX:SVA)(TSX VENTURE:SV) advises that the 2014 Annual General and Special Meeting of shareholders was held at 10.00 am today (Sydney time) at the offices of Dibbs Barker, Level 8, 123 Pitt Street, Sydney, New South Wales, Australia.

All six resolutions that were put before the shareholders were passed on a show of hands.

In respect of resolution 4, in which the Company sought shareholder approval under ASX Listing Rule 7.1A, we confirm that the resolution was passed by a sufficient majority as a special resolution (with 98.44% voting in favour), as set out on the attached page.

The proxy votes received in respect of the various resolutions are set out on the attached page.

For further information, please visit the Company's profile on SEDAR (www.sedar.com) or the Company's website (www.simavita.com) or contact the persons outlined below.

About Simavita

Simavita is a medical device company operating in the digital healthcare sector that has developed an innovative, world first solution for the management of urinary incontinence, with a focus on the elderly. The first product is the SIM™ platform technology which is an instrumented incontinence assessment application that provides evidence based incontinence management care plans to the residential aged care market.

About SIM

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

Proxy results for 2014 Annual General and Special Meeting

Description of Resolution For Against Withhold Non vote
1. Number of Directors
Numbers of votes received 33,833,814 790,949 - 150,222
Percentage of votes cast 97.72 % 2.28 % 0.00 % N/A
2. Election of Directors - Ari Bergman
Numbers of votes received 35,059,823 - 149,923 243,234
Percentage of votes cast 99.57 % 0.00 % 0.43 % N/A
2. Election of Directors - Philippa Lewis
Numbers of votes received 35,056,436 - 86,977 309,567
Percentage of votes cast 99.75 % 0.00 % 0.25 % N/A
2. Election of Directors - Damien Haakman
Numbers of votes received 35,066,917 - 85,090 300,973
Percentage of votes cast 99.76 % 0.00 % 0.24 % N/A
2. Election of Directors - Craig Holland
Numbers of votes received 33,186,652 - 5,127 1,583,206
Percentage of votes cast 99.98 % 0.00 % 0.02 % N/A
3. Appointment of Auditor
Numbers of votes received 35,362,656 - 53,991 36,333
Percentage of votes cast 99.85 % 0.00 % 0.15 % N/A
4. Approval of Increased Placement Capacity
Numbers of votes received 34,674,092 548,098 - 230,790
Percentage of votes cast 98.44 % 1.56 % 0.00 % N/A
5. Approval of Directors' Fees
Numbers of votes received 9,921,199 601,164 - 230,790
Percentage of votes cast 94.29 % 5.71 % 0.00 % N/A
6. Amendment of Stock Option Plan
Numbers of votes received 34,620,267 601,923 - 230,790
Percentage of votes cast 98.29 % 1.71 % 0.00 % N/A

Notes: The Company currently has a total of 73,727,743 common shares on issue and 849 registered share/CDI holders.

Contact Information

  • Company
    Philippa Lewis
    Chief Executive Officer
    +61 2 8405 6381

    Thomas Howitt
    Chief Financial Officer
    + 61 418 351 127

    Media and Investor Relations
    Buchan Consulting
    Annabel Murphy
    amurphy@buchanwe.com.au
    +61 2 9237 2800